AVET PHARMA

Serial Number 88787460
Registration 6323604
700

Registration Progress

Application Filed
Feb 6, 2020
Under Examination
Aug 11, 2020
Approved for Publication
Jun 16, 2020
Published for Opposition
Jun 16, 2020
Registered
Apr 13, 2021

Trademark Image

AVET PHARMA

Basic Information

Serial Number
88787460
Registration Number
6323604
Filing Date
February 6, 2020
Registration Date
April 13, 2021
Published for Opposition
June 16, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 13, 2021
Registration
Registered
Classes
040 042

Rights Holder

Heritage Pharmaceuticals Inc.

03
Address
One Tower Center Blvd., Suite 1700
East Brunswick, NJ 08816

Ownership History

Heritage Pharmaceuticals Inc.

Original Applicant
03
East Brunswick, NJ

Heritage Pharmaceuticals Inc.

Owner at Publication
03
East Brunswick, NJ

Heritage Pharmaceuticals Inc.

Original Registrant
03
East Brunswick, NJ

Legal Representation

Attorney
Matthew A. Homyk

USPTO Deadlines

Next Deadline
622 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-04-13)
Due Date
April 13, 2027
Grace Period Ends
October 13, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
Apr 13, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 12, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 11, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 24, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 24, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 3, 2021 IUAF S USE AMENDMENT FILED Loading...
Feb 3, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 11, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 16, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 16, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 27, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 8, 2020 ALIE A ASSIGNED TO LIE Loading...
Apr 29, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 29, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 29, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 29, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 29, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 27, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 10, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 10, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
Custom manufacture of pharmaceuticals for others; providing technical information in the field of pharmaceutical manufacturing
First Use Anywhere: Jan 29, 2020
First Use in Commerce: Jan 29, 2020
Class 042
Development of pharmaceutical preparations and medicines
First Use Anywhere: Jan 29, 2020
First Use in Commerce: Jan 29, 2020

Classification

International Classes
040 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"